Medication info
Omen Tablet 625 mg (Amoxicillin/Clavulanate Potassium)

Omen Tablet 625 mg (Amoxicillin/Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceutical Co., Ltd.
Appearance
White or almost white oval-shaped film-coated tablets
Packaging
40 tablets (4 tablets/PTP × 10)
Approval status
Active

MFDS item code 200203016 · Notified 2002.06.27 · Insurance code 649501830

Summary

Main use
Treatment of respiratory and otolaryngologic infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and severity of infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose, 3 times daily every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease.)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose, 3 times daily every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, reduce the dose appropriately according to creatinine clearance. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Unimed Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and otolaryngologic infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infection
View approved original text

This medication is used to treat various infections caused by different bacteria. It treats acute and chronic bronchitis, pneumonia, empyema, and lung abscesses, as well as upper respiratory infections such as tonsillitis, sinusitis, and otitis media. It is also effective for urinary tract infections like cystitis, urethritis, and pyelonephritis. The medication is used for skin and soft tissue infections such as pelvic inflammatory disease, gonorrhea, boils, abscesses, cellulitis, and wound infections. It is also helpful in treating severe osteomyelitis and dental infections. This medication is used to improve the symptoms of infection and to assist in healing against various bacteria.

How to take

Adult dose

The dose of this medicine should be determined based on the patient's age, body weight, renal function, and severity of infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose, 3 times daily every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease.)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose, 3 times daily every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, reduce the dose appropriately according to creatinine clearance. Children: Reduce the dose in the same manner.

Precautions

As a beta-lactam antibiotic, this medication should not be administered to patients who have had hypersensitivity reactions to penicillin or cephalosporin drugs. Patients with infectious mononucleosis or lymphocytic leukemia are at higher risk of rash and should be handled with caution. Patients with a history of liver dysfunction should be cautious as this medication may trigger a recurrence of liver dysfunction. Patients with liver impairment should be careful, as its use can worsen liver function. In patients with moderate to severe renal impairment, drug plasma concentration may increase, thus dosing intervals should be adjusted. Allergy-prone individuals or those with a history of bronchial asthma, skin rash, or hives may experience worsening symptoms while using this medication. Patients who have difficulty swallowing, elderly patients, or those with poor general health should be careful, as vitamin K deficiency symptoms may arise. Patients with gastrointestinal disorders such as vomiting or diarrhea should be cautious, as drug absorption may be insufficient. This medication can cause various gastrointestinal side effects, particularly diarrhea and gastroenteritis, in which case, usage should be stopped immediately if symptoms are severe. Abnormal liver function symptoms may also occur, particularly in the elderly and males, and are reported more frequently. Rarely, severe skin allergic reactions may occur, so if rashes or itching develop, intake should be stopped immediately. Blood-related adverse reactions such as leukopenia and thrombocytopenia have been reported infrequently, necessitating regular blood tests. Central nervous system symptoms such as anxiety, confusion, and seizures may occur rarely, and caution is needed in patients with impaired kidney function. In severe renal impairment, acute renal failure or interstitial nephritis may develop, so regular kidney function tests are recommended. Long-term use carries the risk of resistant bacteria and overgrowth of non-susceptible bacteria, thus monitoring is required for treatments lasting more than 14 days. A thorough history should be obtained before administration to check for a history of hypersensitivity to penicillin as serious allergic reactions may develop. Anaphylactic shock can occur, therefore patient states should be closely monitored after administration and emergency care should be prepared. If diarrhea occurs during or after antibiotic use, clostridium difficile infection must be suspected, and immediate medical attention is necessary. This medication may interact with other drugs, so special caution should be taken for patients currently taking anticoagulants, anti-inflammatory drugs, or oral contraceptives. Women who are pregnant or could become pregnant should avoid administration during the first trimester, and breastfeeding mothers should observe their infants for adverse reactions. It is not recommended for children under 12 years or those weighing less than 40 kg. Elderly individuals may exhibit adverse reactions more easily due to decreased body function and should have their dosing and intervals adjusted carefully. This medication may affect certain clinical test results, such as urine sugar tests, and should be considered during testing. In case of overdose, gastrointestinal symptoms, renal failure, seizures, or hypersensitivity shock may be observed, and immediate cessation and proper treatment should be sought. This medication should be stored in a dry place at temperatures below 25 degrees Celcius, and its use should be limited as per doctor's instructions when not needed.

Side effects

Diarrhea, pseudomembranous colitis, indigestion, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, loose stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-associated colitis, severe colitis with bloody stools, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, mucous membrane syndrome, toxic epidermal necrolysis, blistering exfoliative dermatitis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitive vasculitis, dyspnea with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased discharge, agitation, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, antispasmodic, fever, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B deficiency symptoms, linear IgA disease, dysgeusia, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, decreased urination, renal failure, interstitial encephalopathy, hypersensitive shock, skin reactions, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container as it may be sensitive to air or moisture. A cool place between 1 and 25 degrees Celsius is suitable for storage.

Appearance and packaging

Appearance

White or almost white oval-shaped film-coated tablets

Package unit

40 tablets (4 tablets/PTP × 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.